Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Subscribe for $2
Overview
Profile

Quotient stock price, quote, forecast and news

QTNT
JE00BLG2ZQ72
A11598

Price

0.09
Today +/-
+0
Today %
+0 %
P

Quotient stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Quotient stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Quotient stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Quotient stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Quotient's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Quotient Stock Price History

DateQuotient Price
1/19/20230.09 undefined
1/18/20230.09 undefined

Quotient Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Quotient, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Quotient from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Quotient’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Quotient. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Quotient’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Quotient’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Quotient’s growth potential.

Quotient Revenue, EBIT and net profit per share

DateQuotient RevenueQuotient EBITQuotient Net Income
2026e146.17 M undefined-97.56 M undefined-145.44 M undefined
2025e102.1 M undefined-85.63 M undefined-115.63 M undefined
2024e72.75 M undefined-76.66 M undefined-93.76 M undefined
2023e41.05 M undefined-94.37 M undefined-150.51 M undefined
202238.51 M undefined-103.83 M undefined-125.13 M undefined
202143.38 M undefined-82.7 M undefined-111.03 M undefined
202032.66 M undefined-80.39 M undefined-105.14 M undefined
201929.13 M undefined-79.16 M undefined-106.41 M undefined
201824.73 M undefined-69.99 M undefined-82.34 M undefined
201722.23 M undefined-74.06 M undefined-85.07 M undefined
201618.52 M undefined-49.09 M undefined-33.88 M undefined
201518.41 M undefined-29.71 M undefined-59.06 M undefined
201419.76 M undefined-8.89 M undefined-10.17 M undefined
201314.37 M undefined-4.49 M undefined-4.71 M undefined
201212.22 M undefined-3.96 M undefined-4.47 M undefined
201110.03 M undefined-4.1 M undefined-4.62 M undefined

Quotient Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)EBIT (M)EBIT MARGIN (%)NET INCOME (M)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
2011201220132014201520162017201820192020202120222023e2024e2025e2026e
1012141918182224293243384172102146
-20.0016.6735.71-5.26-22.229.0920.8310.3434.38-11.637.8975.6141.6743.14
40.0041.6750.0057.8944.4444.4450.0058.3337.9343.7553.4936.84----
45711881114111423140000
-4-3-4-8-29-49-74-69-79-80-82-103-94-76-85-97
-40.00-25.00-28.57-42.11-161.11-272.22-336.36-287.50-272.41-250.00-190.70-271.05-229.27-105.56-83.33-66.44
-4-4-4-10-59-33-85-82-106-105-111-125-150-93-115-145
---150.00490.00-44.07157.58-3.5329.27-0.945.7112.6120.00-38.0023.6626.09
14.3814.3814.3814.3814.7719.560.71.021.371.792.292.550000
----------------
Details

Keystats

ⓘ

Revenue and Growth

The Quotient Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Quotient is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (M)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (M)TOTAL ASSETS (M)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (M)OTHER EQUITY (k)UNREAL. GAINS/LOSSES (M)EQUITY (M)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (M)DEBT (M)TOTAL CAPITAL (M)
20122013201420152016201720182019202020212022
4.44.27.237.544.120.8125.8394.83120.79111.6767.69
1.51.52.41.82.32.562.863.355.45.326.27
00000000000
2.73.34.64.612.613.6416.2815.5520.522.0122.04
1.41.15.25.62.83.637.073.23.784.875.76
1010.119.449.561.840.6352.04116.93150.47143.88101.75
1.21.78.629.757.163.5360.1647.2961.9361.0862.65
000000000015.47
00000000000
1.21.1110.90.770.910.750.630.620.52
00000000000
000.9005.0410.7312.813.7114.2413.6
2.42.810.530.75869.3471.860.8476.2775.9492.24
12.412.929.980.2119.8109.97123.84177.77226.74219.81193.99
23.8283184.5155.9172.62253.93368.96459.93540.81540.74
-18.3-17.7-16.8-6.711.715.8923.7128.6733.1338.1246.4
-0.4-5.1-15.3-74.4-108.2-193.3-275.64-381.03-488.88-599.91-725.04
100-200300-5,100-12,600-19,292-16,634-14,884-12,672-14,598-6,191
00000000000
5.25-0.8-1.746.8-24.09-14.631.71-8.49-35.58-144.1
2.12.35.37.27.310.785.445.944.834.664.52
1.92.16.511.412.517.1520.6518.6125.7329.827.77
0.100.431000002.921.5
00000000000
00.20.75.21.61.80.960.910.6250.54
4.14.612.954.821.429.7327.0525.4531.1662.3834.33
3.13.315.325.345.998.15104.81142.1177.8166.98256.23
0000000001.151.99
002.41.75.86.186.618.5126.2727.847.05
3.13.317.72751.7104.33111.42150.61204.07195.93305.26
7.27.930.681.873.1134.06138.47176.06235.23258.31339.59
12.412.929.880.1119.9109.97123.84177.77226.74222.73195.49
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Quotient provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Quotient's financial health and stability.

Assets

Quotient's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Quotient must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Quotient after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Quotient's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (k)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES ()TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
201120122013201420152016201720182019202020212022
-4-4-4-10-59-33-85-82-105-102-108-125
000012910121287
00000000001,0000
00036-38-45-32-2
000124-121181112180
000000000000
000000000000
-3-3-3-4-26-46-56-68-75-80-77-119
000-7-23-28-20-21-4-4-4-2
00-1-7-24-28-363-89-304344
000000-1624-84-254746
000000000000
0-201101450-13524091
110438471168411590800
16414858556831451148087
--1.00-----10.00--5.00---3.00
000000000000
-1302306-3915-1314119
000000-76.36-90.02-80.45-85.24-81.82-121.9
000000000000

Quotient stock margins

The Quotient margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Quotient. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Quotient.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Quotient's sales revenue. A higher gross margin percentage indicates that the Quotient retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Quotient's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Quotient's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Quotient's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Quotient. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Quotient's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Quotient Margin History

Quotient Gross marginQuotient Profit marginQuotient EBIT marginQuotient Profit margin
2026e38.8 %-66.75 %-99.5 %
2025e38.8 %-83.87 %-113.24 %
2024e38.8 %-105.37 %-128.89 %
2023e38.8 %-229.9 %-366.64 %
202238.8 %-269.58 %-324.89 %
202153.72 %-190.64 %-255.96 %
202045.49 %-246.16 %-321.96 %
201940.86 %-271.71 %-365.25 %
201857.66 %-282.99 %-332.92 %
201751.21 %-333.19 %-382.73 %
201647.84 %-265.06 %-182.94 %
201546.99 %-161.38 %-320.8 %
201457.44 %-44.99 %-51.47 %
201350.1 %-31.25 %-32.78 %
201244.76 %-32.41 %-36.58 %
201143.97 %-40.88 %-46.06 %

Quotient Stock Sales Revenue, EBIT, Earnings per Share

The Quotient earnings per share therefore indicates how much revenue Quotient has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Quotient earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Quotient's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Quotient’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Quotient's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Quotient Revenue, EBIT and net profit per share

DateQuotient Sales per ShareQuotient EBIT per shareQuotient Earnings per Share
2026e1.08 undefined0 undefined-1.07 undefined
2025e0.75 undefined0 undefined-0.85 undefined
2024e0.54 undefined0 undefined-0.69 undefined
2023e0.3 undefined0 undefined-1.11 undefined
202215.12 undefined-40.75 undefined-49.11 undefined
202118.93 undefined-36.1 undefined-48.47 undefined
202018.24 undefined-44.9 undefined-58.73 undefined
201921.24 undefined-57.7 undefined-77.57 undefined
201824.22 undefined-68.55 undefined-80.65 undefined
201731.59 undefined-105.25 undefined-120.9 undefined
20160.95 undefined-2.51 undefined-1.73 undefined
20151.25 undefined-2.01 undefined-4 undefined
20141.37 undefined-0.62 undefined-0.71 undefined
20131 undefined-0.31 undefined-0.33 undefined
20120.85 undefined-0.28 undefined-0.31 undefined
20110.7 undefined-0.29 undefined-0.32 undefined

Quotient business model

Quotient Ltd is a biopharmaceutical company headquartered in Eysins, Switzerland. The company was founded in 2007 with the aim of developing innovative technologies in the field of Personalized Medicine. This means that medications and therapies are specifically tailored to the individual needs of patients. Thanks to state-of-the-art production processes, products can be produced quickly and safely. Quotient Ltd has a unique business model based on transfusion technology. This technology allows the company to produce medications quickly and accurately. The different components of the medications are separated and then combined in the required dosage. This means that the medications can be precisely dosed and the risks of side effects minimized. A key focus of Quotient Ltd is the development of therapeutics. Personalized medicine and the fast and safe production of medications are at the center of this area. The transfusion technology enables medications to be produced quickly and flexibly, which is particularly important for rare diseases and personalized therapies. Another important area is the development of diagnostics. These enable diseases to be diagnosed quickly and safely. Based on this diagnosis, suitable therapies are then developed. Quotient Ltd also relies on transfusion technology for this, which enables fast, reliable, and flexible production of diagnostics. In addition to its developed technology and know-how, Quotient Ltd also has its own production facility. Here, all products are produced to the highest standards. The production facility covers an area of approximately 6,000 square meters. The modern facility is equipped with the latest technologies and meets the highest quality standards. Quotient Ltd offers a variety of products, with a special focus on personalized medicine and the fast and safe production of medications and diagnostics. One example is the PDA diagnostic system, which was developed for the fast and accurate diagnosis of autoimmune diseases. The MosaiQ system is another important product that enables fast and reliable production of medications. The success story of Quotient Ltd is closely linked to the development of transfusion technology. The company has succeeded in developing a technology that allows for the fast and safe production of personalized medicine. This technology has made Quotient Ltd a leading company in the field of personalized medicine worldwide. Today, Quotient Ltd employs over 700 people who are constantly working on the further development of personalized medicine and transfusion technology. Quotient is one of the most popular companies on Eulerpool.com.

Quotient SWOT Analysis

Strengths

1. Unique Technology: Quotient Ltd possesses a proprietary technology platform that allows for rapid, accurate, and cost-effective testing of blood samples.

2. Strong Intellectual Property: The company holds a significant number of patents and licenses, providing a competitive advantage and barriers to entry for potential competitors.

3. Established Market Presence: Quotient Ltd has a strong presence in the global diagnostic testing market, with a wide customer base including hospitals, clinical laboratories, and blood banks.

Weaknesses

1. Dependence on Key Customers: Quotient Ltd relies heavily on a few major customers for a significant portion of its revenue, which exposes it to the risk of losing key accounts.

2. Limited Product Portfolio: The company's product offering is currently focused on the immunoassay diagnostics segment, which may limit its growth potential in other diagnostic areas.

3. Vulnerability to Regulatory Changes: Quotient Ltd operates in a highly regulated industry, making it susceptible to changes in government policies and regulations that may impact its operations and market access.

Opportunities

1. Expansion into New Markets: Quotient Ltd has the potential to penetrate untapped markets such as emerging economies where there is a growing demand for advanced diagnostic solutions.

2. Strategic Partnerships and Acquisitions: Collaborations with strategic partners or acquiring complementary businesses can enhance Quotient Ltd's product portfolio and market reach.

3. Increasing Demand for Personalized Medicine: The trend towards personalized medicine presents an opportunity for Quotient Ltd to develop diagnostic tests tailored to individual patients, thereby addressing the evolving needs of the healthcare industry.

Threats

1. Intense Competition: The diagnostic testing market is highly competitive, with numerous established players and new entrants constantly emerging, posing a threat to Quotient Ltd's market share and pricing power.

2. Technological Advancements: Rapid advancements in technology may render Quotient Ltd's current testing platform obsolete if it fails to keep up with the pace of innovation.

3. Economic Instability: Economic downturns or fluctuations can impact healthcare spending, potentially leading to reduced demand for Quotient Ltd's diagnostic products and services.

Quotient Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Quotient historical P/E ratio, EBIT, and P/S ratio.

Quotient shares outstanding

The number of shares was Quotient in 2023 — This indicates how many shares 2.548 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Quotient earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Quotient's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Quotient’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Quotient's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Quotient Stock splits

In Quotient's history, there have been no stock splits.
Unfortunately, there are currently no price targets and forecasts available for Quotient.

Quotient list of shareholders

%
Name
Stocks
Change
Date
7.49 % Pura Vida Investments, LLC10,157,4081,506,9913/31/2022
6.82 % Polar Capital LLP9,251,65303/31/2022
6.72 % Highbridge Capital Management, LLC9,117,2571,776,1543/31/2022
5.40 % Galen Partners7,329,07407/14/2021
4.54 % Maven Investment Partners US Ltd.6,158,225-4,469,9557/5/2022
3.69 % BlackRock Institutional Trust Company, N.A.5,003,158-42,9573/31/2022
3.47 % Morgan Stanley Investment Management Inc. (US)4,705,9141,197,3243/31/2022
3.14 % ClearBridge Investments, LLC4,255,90833,4093/31/2022
2.71 % Columbia Threadneedle Investments (US)3,673,368-1,477,4263/31/2022
2.00 % TimesSquare Capital Management, LLC2,718,171-45,3003/31/2022
1
2
3
4
5
...
10

Quotient Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
Open Orphan Stock
Open Orphan
SupplierCustomer0,830,91-0,030,730,870,04
STRATEC Stock
STRATEC
SupplierCustomer-0,360,710,660,790,57-0,13
Ortho Cli Dgnst Rg Stock
Ortho Cli Dgnst Rg
SupplierCustomer-0,530,150,400,580,79-
Merck Stock
Merck
SupplierCustomer-0,640,470,600,870,04-0,78
Bio-Rad Laboratories A Stock
Bio-Rad Laboratories A
SupplierCustomer-0,78-0,100,810,910,68-0,37
Grifols A Stock
Grifols A
SupplierCustomer-0,80-0,95-0,69-0,390,740,86
1

Most common questions regarding Quotient

What values and corporate philosophy does Quotient represent?

Quotient Ltd represents a set of core values and corporate philosophy that guide its operations. The company emphasizes innovation, aiming to develop and deliver novel solutions in the diagnostics field. With a strong focus on precision medicine, Quotient Ltd also prioritizes accuracy and reliability in its products and services. The company values collaboration and partnerships, continually seeking to forge relationships that drive advancements in healthcare. Furthermore, Quotient Ltd is committed to high ethical standards, ensuring transparency and integrity in its conduct. By embodying these values and corporate philosophy, Quotient Ltd strives to make a positive impact in the healthcare industry.

In which countries and regions is Quotient primarily present?

Quotient Ltd is primarily present in various countries and regions across the globe. The company has a global presence, with significant operations in the United States, Europe, and Asia-Pacific. Quotient Ltd has established a strong foothold in these key markets, allowing it to effectively serve its customers and expand its reach. With a wide presence in multiple countries and regions, Quotient Ltd continues to strengthen its position as a prominent player in the stock market industry.

What significant milestones has the company Quotient achieved?

Quotient Ltd, a leading diagnostics company, has achieved several significant milestones. The company introduced MosaiQ, its game-changing platform which revolutionizes transfusion diagnostics. Quotient Ltd successfully launched the MosaiQ Early Warnings Score, a novel risk stratification tool for assessing disease severity in critically ill patients. The company also achieved CE Marking for the MosaiQ™ Zika and Calibrator Panel, reinforcing its commitment to advancing diagnostics for infectious diseases. Quotient Ltd's collaborations with renowned institutions have further contributed to its success, including partnerships with Ortho Clinical Diagnostics and the Red Cross. These milestones showcase Quotient Ltd's dedication to innovation and its impact on improving patient outcomes in the field of diagnostics.

What is the history and background of the company Quotient?

Quotient Ltd is a renowned company with a rich history and background. It was founded in 2007 and is headquartered in Eysins, Switzerland. Originally known as Inverness Medical Innovations, the company rebranded as Alere Inc. in 2011 before becoming Quotient Limited in 2017. Quotient is a commercial-stage diagnostics company that focuses on transforming transfusion diagnostics, delivering innovative products to optimize patient care. With its cutting-edge technology and expertise, Quotient aims to address unmet needs in blood typing and screening, helping to improve the safety and efficiency of transfusion medicine. Quotient Ltd continues to make significant contributions in the field of diagnostics and healthcare.

Who are the main competitors of Quotient in the market?

Some of the main competitors of Quotient Ltd in the market include companies like Hologic Inc., Immucor Inc., and Grifols S.A. These companies also operate in the field of diagnostics and blood testing solutions, potentially competing with Quotient Ltd in terms of product offerings and market share. However, Quotient Ltd has built a strong reputation and market presence with its innovative technologies and services.

In which industries is Quotient primarily active?

Quotient Ltd is primarily active in the field of diagnostics and healthcare. As a global leader, Quotient specializes in developing innovative products and technologies for blood grouping and infectious disease testing. The company provides customized solutions to the blood transfusion and transplantation markets, ensuring the safety and accuracy of patient testing. With a focus on enhancing efficiency and reducing costs, Quotient offers a comprehensive range of products that cater to the needs of healthcare providers worldwide. Through their cutting-edge solutions, Quotient Ltd plays a crucial role in improving public health outcomes and supporting healthcare professionals in diagnosing and treating patients effectively.

What is the business model of Quotient?

The business model of Quotient Ltd focuses on the development and commercialization of innovative transfusion diagnostics solutions. Quotient's MosaiQ™ technology platform enables the provision of a wide range of serological tests on a single system. This advanced platform merges automated microarray technology with proprietary chemistry and software, allowing for high-throughput testing and efficient resource allocation. With its unique offering, Quotient Ltd aims to enhance patient outcomes and optimize laboratory efficiency in the field of blood transfusion diagnostics.

What is the P/E ratio of Quotient 2024?

The Quotient P/E ratio is -0.

What is the P/S ratio of Quotient 2024?

The Quotient P/S ratio is 0.

What is the AlleAktien quality score of Quotient?

The AlleAktien quality score for Quotient is 7/10.

What is the revenue of Quotient 2024?

The expected Quotient revenue is 72.75 M USD.

How high is the profit of Quotient 2024?

The expected Quotient profit is -93.76 M USD.

What is the business model of Quotient

Quotient Ltd is a global company that offers innovative technologies and services for the pharmaceutical and biotech industry. The company employs over a thousand employees and is headquartered in Eysins, Switzerland. Its business model includes various divisions, with a focus on science, research, and the development of drugs and biotech products. The main areas of business are drug development services, manufacturing sciences & services, diagnostic solutions, immunoassays & bioassays, and digital health and AI. Quotient Ltd has developed a wide range of products for use in various fields, including assay ready cells, transfection reagents and electrodes, particle cleaning and analysis devices, and various assays and tests for genetic variations and drug determination. The company aims to push the boundaries of science and research and improve the effectiveness of drugs and biotech products. Through continuous investments in research and development, innovative technologies and services, and a focus on customer needs, Quotient Ltd has successfully positioned itself as a leading provider in the biotech industry. The company's $100 million in revenue and collaborations with global players such as GSK, Merck, and Sanofi attest to its economic success.

What is the Quotient dividend?

Quotient pays a dividend of 0 USD distributed over payouts per year.

How often does Quotient pay dividends?

The dividend cannot currently be calculated for Quotient or the company does not pay out a dividend.

What is the Quotient ISIN?

The ISIN of Quotient is JE00BLG2ZQ72.

What is the Quotient WKN?

The WKN of Quotient is A11598.

What is the Quotient ticker?

The ticker of Quotient is QTNT.

How much dividend does Quotient pay?

Over the past 12 months, Quotient paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Quotient is expected to pay a dividend of 0 USD.

What is the dividend yield of Quotient?

The current dividend yield of Quotient is .

When does Quotient pay dividends?

Quotient pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Quotient?

Quotient paid dividends every year for the past 0 years.

What is the dividend of Quotient?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Quotient located?

Quotient is assigned to the 'Health' sector.

Wann musste ich die Aktien von Quotient kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Quotient from 8/28/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 8/28/2024.

When did Quotient pay the last dividend?

The last dividend was paid out on 8/28/2024.

What was the dividend of Quotient in the year 2023?

In the year 2023, Quotient distributed 0 USD as dividends.

In which currency does Quotient pay out the dividend?

The dividends of Quotient are distributed in USD.

All fundamentals about Quotient

Our stock analysis for Quotient Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Quotient Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.